G1 Therapeutics, Inc.
Synthesis of n-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines
Last updated:
Abstract:
This invention is in the area of synthesizing pyrimidine-based compounds useful in the treatment of disorders involving abnormal cellular proliferation, including but not limited to tumors and cancers.
Status:
Grant
Type:
Utility
Filling date:
21 Dec 2018
Issue date:
15 Dec 2020